Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 4/20 | 0.37 |
| ▸ | AKR1C2 | P52895 | 4/20 | 0.37 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.37 |
| ▸ | CPA1 | P15085 | 1/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | HTR1A | P08908 | 1/20 | 0.37 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7878181 | 0.85 | EPHX1 (0.37) | TSHRLMNAHSD17B10NAPRTKDM4E | |
| SCHEMBL1471743 | 0.82 | CPB2 (0.42) | LMNAMAPT | |
| SCHEMBL1233844 | 0.81 | TSHR (0.41) | CPA1TSHRHSD17B10NAPRTKDM4E | |
| SCHEMBL28372820 | 0.81 | KMT2A (0.38) | KDM4EGAAMAPTPOLB | |
| SCHEMBL2927175 | 0.80 | CPB2 (0.43) | LMNAMAPT | |
| SCHEMBL10513500 | 0.80 | CPB2 (0.36) | CPA1TSHRNAPRTKDM4EGAA | |
| SCHEMBL27505419 | 0.79 | CPB2 (0.45) | CPA1TSHRNAPRTKDM4EGAA | |
| SCHEMBL9666581 | 0.76 | CPA1 (0.34) | CPA1TSHRNAPRTKDM4EGAA | |
| SCHEMBL27842250 | 0.76 | CNR1 (0.47) | CPA1TSHRGAA | |
| SCHEMBL27670390 | 0.76 | RAB9A (0.37) | TSHRHSD17B10NAPRTKDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10167501-B2 | Methods and apparatus for quantification of nucleic acid amplification by monitoring impedances | AUCKLAND UNISERVICES LIMITED (NZ) | 2019-01-01 | — | — | US | claimed |
| US-20160046977-A1 | Methods and Apparatus for Amplifying Nucleic Acids | AUCKLAND UNISERVICES LIMITED (NZ) | 2016-02-18 | — | — | US | claimed |
| CN-120077040-A | Compounds for SHP2 protein degradation and medical uses thereof | 尤比克斯治疗公司 | 2025-05-30 | — | — | CN | disclosed |
| US-10167501-B2 | Methods and apparatus for quantification of nucleic acid amplification by monitoring impedances | AUCKLAND UNISERVICES LIMITED (NZ) | 2019-01-01 | — | — | US | disclosed |
| US-20160046977-A1 | Methods and Apparatus for Amplifying Nucleic Acids | AUCKLAND UNISERVICES LIMITED (NZ) | 2016-02-18 | — | — | US | disclosed |
| WO-2003099801-A1 | NOVEL ANTI-INFECTIVES | SMITHKLINE BEECHAM CORPORATION (US) | 2003-12-04 | — | — | WO | disclosed |
| CN-1016869-B | Process for preparing 6, 7-diacyl-7-deacetylforskolin derivatives | NIPPON KAYAKU KK (JP) | 1992-06-03 | — | — | CN | disclosed |
| CN-1016507-B | Process for preparation of forskolin derivatives | NIPPON KAYAKU KK (JP) | 1992-05-06 | — | — | CN | disclosed |
| CN-1030583-A | Preparation 6,7-diacyl-7-takes off the novel method of acetyl forskrine derivant | NIPPON KAYAKU KK (JP) | 1989-01-25 | — | — | CN | disclosed |
| CN-86107826-A | New forskrine derivant | — | 1987-10-14 | — | — | CN | disclosed |